Settlement and Payment Agreements (Details Narrative) - USD ($)								3 Months Ended
	Mar. 14, 2023	Mar. 28, 2022	Sep. 14, 2021	Aug. 01, 2021	May 29, 2020	Feb. 21, 2020	Jan. 18, 2017	Mar. 31, 2023	Jun. 30, 2023	Feb. 15, 2023	Dec. 31, 2022	Dec. 30, 2022	Dec. 15, 2022	Aug. 01, 2022	Mar. 31, 2022	Jan. 31, 2022	Dec. 31, 2021	Apr. 29, 2021	Feb. 26, 2018	Jul. 21, 2016
Debt Instrument [Line Items]
Accounts payable									$ 5,889,542		$ 5,724,390
Related Party [Member]
Debt Instrument [Line Items]
Due to related parties, current									431,693
Sharp Clinical Services Inc [Member]
Debt Instrument [Line Items]
Late payment fees						$ 103,890
Loss contingency, value					$ 104,217
Payments for legal settlements				$ 75,000		$ 10,000
Payments for fees		$ 415
Sharp Clinical Services Inc [Member] | Related Party [Member]
Debt Instrument [Line Items]
Due to related parties, current								$ 53,568
Salamandra LLC [Member]
Debt Instrument [Line Items]
Attorneys fees and cost							$ 47,937
Percentage of accrued interest																			4.50%
Accrued interest									43,376
Salamandra LLC [Member] | Related Party [Member]
Debt Instrument [Line Items]
Due to related parties, current							$ 146,082
Investment Banking Services [Member]
Debt Instrument [Line Items]
Accrued expenses																				$ 225,000
Second Amendment [Member]
Debt Instrument [Line Items]
Investment owned, face amount											$ 200,000		$ 100,000
Notes payable													$ 75,000
Percentage of royalty on net sales													4.00%
Second Amendment [Member] | Minimum [Member]
Debt Instrument [Line Items]
Notes payable													$ 10,000
Settlement Agreement [Member] | Former Legal Counsel [Member]
Debt Instrument [Line Items]
Investment owned, face amount												$ 250,000		$ 2,608,914
Notes payable										$ 350,000
Accounts payable									2,608,914
Employment Agreement Termination And Separation Agreement [Member]
Debt Instrument [Line Items]
Notes payable																$ 789,267
Payment and Settlement Agreement [Member] | Convertible Notes Payable [Member] | University of California Innovation and Entrepreneurship [Member]
Debt Instrument [Line Items]
Notes payable															$ 175,000			$ 234,657
Agreed payment value																		$ 10,000
Accounts payable									234,657
Payment of debt								234,657
Sharp Settlement Agreement [Member]
Debt Instrument [Line Items]
Repayments of related party debt								$ 30,000
DNA Healthlink Settlement Agreement [Member] | DNA Healthlink Inc [Member]
Debt Instrument [Line Items]
Notes payable			$ 390,000
Accounts Payable, Trade, Current			410,000
Vendor Settlement																	$ 8,000
Long-Term Debt									$ 74,000
DNA Healthlink Settlement Agreement [Member] | DNA Healthlink Inc [Member] | November 15, 2021 [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment			8,000
DNA Healthlink Settlement Agreement [Member] | DNA Healthlink Inc [Member] | November 15, 2022 [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment			10,000
DNA Healthlink Settlement Agreement [Member] | DNA Healthlink Inc [Member] | November 15, 2023 [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment			15,000
DNA Healthlink Settlement Agreement [Member] | DNA Healthlink Inc [Member] | November 15, 2024 [Member]
Debt Instrument [Line Items]
Debt Instrument, Periodic Payment			$ 14,000
DNA Healthlink Settlement Agreement [Member] | Upfront Fees [Member] | DNA Healthlink Inc [Member]
Debt Instrument [Line Items]
Payments for fees	$ 15,000,000.00